Table of Contents
ISRN Neurology
Volume 2012, Article ID 427102, 6 pages
http://dx.doi.org/10.5402/2012/427102
Review Article

Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric Populations

Department of Psychiatry, School of Medicine and University Hospital of Patras, University of Patras, Rio, 26504 Patras, Greece

Received 26 August 2012; Accepted 17 September 2012

Academic Editors: M. G. Grasso and Y. Wang

Copyright © 2012 Maria Skokou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Paparrigopoulos, P. Ferentinos, A. Kouzoupis, G. Koutsis, and G. N. Papadimitriou, “The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour,” International Review of Psychiatry, vol. 22, no. 1, pp. 14–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Koutsouraki, V. Costa, and S. Baloyannis, “Epidemiology of multiple sclerosis in Europe: a review,” International Review of Psychiatry, vol. 22, no. 1, pp. 2–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Kantarci and D. Wingerchuk, “Epidemiology and natural history of multiple sclerosis: new insights,” Current Opinion in Neurology, vol. 19, no. 3, pp. 248–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Chitnis, B. Glanz, S. Jaffin, and B. Healy, “Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States,” Multiple Sclerosis, vol. 15, no. 5, pp. 627–631, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Butler and T. L. Bennett, “In search of a conceptualization of multiple sclerosis: a historical perspective,” Neuropsychology Review, vol. 13, no. 2, pp. 93–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Marrie, R. Horwitz, G. Cutter, T. Tyry, D. Campagnolo, and T. Vollmer, “The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated,” Multiple Sclerosis, vol. 15, no. 3, pp. 385–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Raskind, “Diagnosis and treatment of depression comorbid with neurologic disorders,” American Journal of Medicine, vol. 121, no. 11, pp. S28–S37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Goldman Consensus Group, “The Goldman Consensus statement on depression in multiple sclerosis,” Multiple Sclerosis, vol. 11, no. 3, pp. 328–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. B. Patten, S. Berzins, and L. M. Metz, “Challenges in screening for depression in multiple sclerosis,” Multiple Sclerosis, vol. 16, no. 11, pp. 1406–1411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Chwastiak, D. M. Ehde, L. E. Gibbons, M. Sullivan, J. D. Bowen, and G. H. Kraft, “Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample,” American Journal of Psychiatry, vol. 159, no. 11, pp. 1862–1868, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. D. M. Weisbrot, A. B. Ettinger, K. D. Gadow et al., “Psychiatric comorbidity in pediatric patients with demyelinating disorders,” Journal of Child Neurology, vol. 25, no. 2, pp. 192–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Feinstein, “Multiple sclerosis and depression,” Multiple Sclerosis Journal, vol. 17, no. 11, pp. 1276–1281, 2011. View at Google Scholar
  13. S. B. Patten, L. M. Metz, and M. A. Reimer, “Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population,” Multiple Sclerosis, vol. 6, no. 2, pp. 115–120, 2000. View at Google Scholar · View at Scopus
  14. L. D. Jacobs, R. W. Beck, J. H. Simon et al., “Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis,” The New England Journal of Medicine, vol. 343, no. 13, pp. 898–904, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Siegert and D. A. Abernethy, “Depression in multiple sclerosis: a review,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 4, pp. 469–475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. B. Patten and L. M. Metz, “Interferon β-1a and depression in relapsing-remitting multiple sclerosis: An analysis of depression data from the PRISMS clinical trial,” Multiple Sclerosis, vol. 7, no. 4, pp. 243–248, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Feinstein, P. O'Connor, and K. Feinstein, “Multiple sclerosis, interferon beta-1b and depression: a prospective investigation,” Journal of Neurology, vol. 249, no. 7, pp. 815–820, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Mohr, D. E. Goodkin, J. Islar, S. L. Hauser, and C. P. Genain, “Treatment of depression is associated with suppression of nonspecific and antigen-specific TH1 responses in multiple sclerosis,” Archives of Neurology, vol. 58, no. 7, pp. 1081–1086, 2001. View at Google Scholar · View at Scopus
  19. L. Messinis, M. H. Kosmidis, E. Lyros, and P. Papathanasopoulos, “Assessment and rehabilitation of cognitive impairment in multiple sclerosis,” International Review of Psychiatry, vol. 22, no. 1, pp. 22–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. C. Mohr, D. E. Goodkin, W. Likosky, N. Gatto, K. A. Baumann, and R. A. Rudick, “Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis,” Archives of Neurology, vol. 54, no. 5, pp. 531–533, 1997. View at Google Scholar · View at Scopus
  21. O. Kargiotis, A. Paschali, L. Messinis, and P. Papathanasopoulos, “Quality of life in multiple sclerosis: effects of current treatment options,” International Review of Psychiatry, vol. 22, no. 1, pp. 67–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. P. Turner, R. M. Williams, J. D. Bowen, D. R. Kivlahan, and J. K. Haselkorn, “Suicidal ideation in multiple sclerosis,” Archives of Physical Medicine and Rehabilitation, vol. 87, no. 8, pp. 1073–1078, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. E. D. Caine and S. R. Schwid, “Multiple sclerosis, depression, and the risk of suicide,” Neurology, vol. 59, no. 5, pp. 662–663, 2002. View at Google Scholar · View at Scopus
  24. C. McGuigan and M. Hutchinson, “Unrecognised symptoms of depression in a community-based population with multiple sclerosis,” Journal of Neurology, vol. 253, no. 2, pp. 219–223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. H. L. Tremlett, D. K. Luscombe, and C. M. Wiles, “Prescribing for multiple sclerosis patients in general practice: a case-control study,” Journal of Clinical Pharmacy and Therapeutics, vol. 26, no. 6, pp. 437–444, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Cetin, K. L. Johnson, D. M. Ehde, C. M. Kuehn, D. Amtmann, and G. H. Kraft, “Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample,” Multiple Sclerosis, vol. 13, no. 8, pp. 1046–1053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. D. C. Mohr, S. L. Hart, I. Fonareva, and E. S. Tasch, “Treatment of depression for patients with multiple sclerosis in neurology clinics,” Multiple Sclerosis, vol. 12, no. 2, pp. 204–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders-Clinical Descriptions and Diagnostic Guidelines, WHO, Geneva, Switzerland, 1993.
  29. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders-DSM-IV-TR, APA, American Psychiatric Publishing, Arlington, Va, USA, 4th ed edition, 2000.
  30. H. S. Akiskal, “Mood disorders: clinical features,” in Comprehensive Textbook of Psychiatry, V. A. Sadock, #x26, and V. A. Sadock, Eds., Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2009. View at Google Scholar
  31. J. J. Gallo and P. V. Rabins, “Depression without sadness: alternative presentations of depression in late life,” American Family Physician, vol. 60, no. 3, pp. 820–826, 1999. View at Google Scholar · View at Scopus
  32. E. A. Leventhal, S. Hansell, M. Diefenbach, H. Leventhal, and D. C. Glass, “Negative affect and self-report of physical symptoms: two longitudinal studies of older adults,” Health Psychology, vol. 15, no. 3, pp. 193–199, 1996. View at Google Scholar · View at Scopus
  33. C. McGuigan, A. McCarthy, and M. Hutchinson, “Influence of depression on self reporting of the physical impact of multiple sclerosis in two community based populations,” Journal of Neurology Neurosurgery and Psychiatry, vol. 74, no. 3, pp. 408–408, 2003. View at Google Scholar
  34. M. A. Whooley, A. L. Avins, J. Miranda, and W. S. Browner, “Case-finding instruments for depression: two questions are as good as many,” Journal of General Internal Medicine, vol. 12, no. 7, pp. 439–445, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. D. C. Mohr, S. L. Hart, L. Julian, and E. S. Tasch, “Screening for depression among patients with multiple sclerosis: two questions may be enough,” Multiple Sclerosis, vol. 13, no. 2, pp. 215–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. S. Lachs, A. R. Feinstein, L. M. Cooney et al., “A simple procedure for general screening for functional disability in elderly patients,” Annals of Internal Medicine, vol. 112, no. 9, pp. 699–706, 1990. View at Google Scholar · View at Scopus
  37. J. R. Avasarala, A. H. Cross, and K. Trinkaus, “Comparative assessment of yale single question and Beck depression inventory Scale in screening for depression in multiple sclerosis,” Multiple Sclerosis, vol. 9, no. 3, pp. 307–310, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, and J. Erbaugh, “An inventory for measuring depression,” Archives of General Psychiatry, vol. 4, no. 6, pp. 561–571, 1961. View at Google Scholar · View at Scopus
  39. A. T. Beck and G. K. Brown, Eds., BDI-Fast Screen for Medical Patients: Manual, Psychological Corporation, San Antonio, Tex, USA, 2000.
  40. R. H. B. Benedict, I. Fishman, M. M. McClellan, R. Bakshi, and B. Weinstock-Guttman, “Validity of Beck Depression Inventory-Fast Screen in multiple sclerosis,” Multiple Sclerosis, vol. 9, no. 4, pp. 393–396, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Google Scholar · View at Scopus
  42. C. Herrmann, “International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results,” Journal of Psychosomatic Research, vol. 42, no. 1, pp. 17–41, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Honarmand and A. Feinstein, “Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients,” Multiple Sclerosis, vol. 15, no. 12, pp. 1518–1524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. I. McDowell, Ed., Measuring Health, a Guide to Rating Scales and Questionnaires, Oxford University Press, New York, NY, USA, 1996.
  45. S. B. Patten, S. Fridhandler, C. A. Beck, and L. M. Metz, “Depressive symptoms in a treated multiple sclerosis cohort,” Multiple Sclerosis, vol. 9, no. 6, pp. 616–620, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. D. L. Nyenhuis, T. Luchetta, C. Yamamoto et al., “The development, standardization, and initial validation of the Chicago Multiscale Depression Inventory,” Journal of Personality Assessment, vol. 70, no. 2, pp. 386–401, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Solari, A. Motta, L. Mendozzi et al., “Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis,” Neurological Sciences, vol. 24, no. 6, pp. 375–383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 23, pp. 56–62, 1960. View at Google Scholar · View at Scopus
  49. P. J. Moran and D. C. Mohr, “The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis,” Journal of Behavioral Medicine, vol. 28, no. 1, pp. 35–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Radat, M. Lafittau, J. C. Ouallet, B. Brochet, and R. Jouvent, “Validation of EHD self questionnaire in multiple sclerosis,” Encephale, vol. 33, no. 1, pp. 49–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. W. W. ZUNG, “A self-rating depression scale,” Archives of General Psychiatry, vol. 12, pp. 63–70, 1965. View at Google Scholar · View at Scopus
  52. K. K. Leung, B. H. Lue, M. B. Lee, and L. Y. Tang, “Screening of depression in patients with chronic medical diseases in a primary care setting,” Family Practice, vol. 15, no. 1, pp. 67–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. D. C. Kroencke, S. G. Lynch, and D. R. Denney, “Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern,” Multiple Sclerosis, vol. 6, no. 2, pp. 131–136, 2000. View at Google Scholar · View at Scopus
  54. S. Fruewald, H. Loeffler-Stastka, R. Eher, B. Saletu, and U. Baumhacki, “Depression and quality of life in multiple sclerosis,” Acta Neurologica Scandinavica, vol. 104, no. 5, pp. 257–261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. S. A. Montgomery and M. Asberg, “A new depression scale designed to be sensitive to change,” British Journal of Psychiatry, vol. 134, no. 4, pp. 382–389, 1979. View at Google Scholar · View at Scopus
  56. S. R. Montel and C. Bungener, “Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis,” Multiple Sclerosis, vol. 13, no. 3, pp. 393–401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. I. A. Ketelslegers, C. E. Catsman-Berrevoets, M. Boon et al., “Fatigue and depression in children with multiple sclerosis and monophasic variants,” European Journal of Paediatric Neurology, vol. 14, no. 4, pp. 320–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Goretti, E. Portaccio, A. Ghezzi et al., “Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis,” Multiple Sclerosis Journal, vol. 18, no. 3, pp. 329–334, 2012. View at Google Scholar
  59. J. Kaufman, B. Birmaher, D. Brent et al., “Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 36, no. 7, pp. 980–988, 1997. View at Google Scholar · View at Scopus
  60. A. C. Sollom and I. I. Kneebone, “Treatment of depression in people who have multiple sclerosis,” Multiple Sclerosis, vol. 13, no. 5, pp. 632–635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Bristow and S. Patten, “Treatment-seeking rates and associated mediating factors among individuals with depression,” Canadian Journal of Psychiatry, vol. 47, no. 7, pp. 660–665, 2002. View at Google Scholar · View at Scopus
  62. J. A. Wilken and C. Sullivan, “Recognizing and treating common psychiatric disorders in multiple sclerosis,” Neurologist, vol. 13, no. 6, pp. 343–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. D. C. Mohr, S. L. Hart, and A. Goldberg, “Effects of treatment for depression on fatigue in multiple sclerosis,” Psychosomatic Medicine, vol. 65, no. 4, pp. 542–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Hart, I. Fonareva, N. Merluzzi, and D. C. Mohr, “Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients,” Quality of Life Research, vol. 14, no. 3, pp. 695–703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. P. E. Sijens, J. P. Mostert, R. Irwan, J. H. Potze, M. Oudkerk, and J. De Keyser, “Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging,” Psychiatry Research, vol. 164, no. 3, pp. 274–282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Musgrave, C. Benson, G. Wong et al., “The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE),” Brain, Behavior, and Immunity, vol. 25, no. 8, pp. 1677–1688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. C. I. Mitsonis, I. M. Zervas, C. M. Potagas et al., “Effects of escitalopram on stress-related relapses in women with multiple sclerosis: an open-label, randomized, controlled, one-year follow-up study,” European Neuropsychopharmacology, vol. 20, no. 2, pp. 123–131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Ramasubbu, V. H. Taylor, Z. Saaman et al., “The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions,” Annals of Clinical Psychiatry, vol. 24, no. 1, pp. 91–109, 2012. View at Google Scholar
  69. M. W. Koch, A. Glazenborg, M. Uyttenboogaart, J. Mostert, and J. De Keyser, “Pharmacologic treatment of depression in multiple sclerosis,” Cochrane Database of Systematic Reviews, vol. 2, Article ID CD007295, 2011. View at Google Scholar · View at Scopus
  70. R. B. Schiffer and N. M. Wineman, “Antidepressant pharmacotherapy of depression associated with multiple sclerosis,” American Journal of Psychiatry, vol. 147, no. 11, pp. 1493–1497, 1990. View at Google Scholar · View at Scopus
  71. D. M. Ehde, G. H. Kraft, L. Chwastiak et al., “Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis,” General Hospital Psychiatry, vol. 30, no. 1, pp. 40–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. D. C. Mohr, A. C. Boudewyn, D. E. Goodkin, A. Bostrom, and L. Epstein, “Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis,” Journal of Consulting and Clinical Psychology, vol. 69, no. 6, pp. 942–949, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. T. F. Scott, P. Nussbaum, H. McConnell, and P. Brill, “Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale,” Neurological Research, vol. 17, no. 6, pp. 421–422, 1995. View at Google Scholar · View at Scopus
  74. F. Benedetti, E. Campori, C. Colombo, and E. Smeraldi, “Fluvoxamine treatment of major depression associated with multiple sclerosis,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 16, no. 3, pp. 364–366, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Barak, E. Ur, and A. Achiron, “Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 11, no. 2, pp. 271–273, 1999. View at Google Scholar · View at Scopus
  76. Y. Barak, A. Achiron, D. Shoshani, and A. Elizur, “Fluoxetine treatment of depression in patients suffering from multiple sclerosis,” Human Psychopharmacology-Clinical and Experimental, vol. 13, no. 1, pp. 66–67, 1998. View at Google Scholar
  77. E. A. Yeh, “Current therapeutic options in pediatric multiple sclerosis,” Current Treatment Options in Neurology, vol. 13, no. 6, pp. 544–559, 2011. View at Google Scholar
  78. K. G. Rasmussen and B. M. Keegan, “Electroconvulsive therapy in patients with multiple sclerosis,” Journal of ECT, vol. 23, no. 3, pp. 179–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. E. Corruble, H. Awad, G. Chouinard, and P. Hardy, “ECT in delusional depression with multiple sclerosis,” American Journal of Psychiatry, vol. 161, no. 9, p. 1715, 2004. View at Google Scholar · View at Scopus
  80. M. T. Wallin, J. A. Wilken, A. P. Turner, R. M. Williams, and R. Kane, “Depression and multiple sclerosis: review of a lethal combination,” Journal of Rehabilitation Research and Development, vol. 43, no. 1, pp. 45–62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. G. Mattingly, K. Baker, C. F. Zorumski, and G. S. Figiel, “Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 4, no. 2, pp. 145–151, 1992. View at Google Scholar · View at Scopus
  82. D. C. Mohr and D. E. Goodkin, “Treatment of depression in multiple sclerosis: review and meta-analysis,” Clinical Psychology: Science and Practice, vol. 6, no. 1, pp. 1–9, 1999. View at Google Scholar · View at Scopus
  83. R. Litta, “Non-pharmacological treatment of depression,” Neurological Sciences, vol. 27, no. 4, pp. S344–S346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. D. C. Mohr, S. L. Hart, L. Julian et al., “Telephone-administered psychotherapy for depression,” Archives of General Psychiatry, vol. 62, no. 9, pp. 1007–1014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. D. S. Dorstyn, J. L. Mathias, and L. A. Denson, “Psychosocial outcomes of telephone-based counseling for adults with an acquired physical disability: a meta-analysis,” Rehabilitation Psychology, vol. 56, no. 1, pp. 1–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. C. L. Cooper, D. Hind, G. D. Parry et al., “Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial,” Trials, vol. 12, article 259, 2011. View at Google Scholar
  87. R. Moss-Morris, P. McCrone, L. Yardley, K. van Kessel, G. Wills, and L. Dennison, “A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue,” Behaviour Research and Therapy, vol. 50, no. 6, pp. 415–421, 2012. View at Google Scholar
  88. A. Stathopoulou, P. Christopoulos, E. Soubasi, and P. Gourzis, “Personality characteristics and disorders in multiple sclerosis patients: assessment and treatment,” International Review of Psychiatry, vol. 22, no. 1, pp. 43–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. P. Grossman, L. Kappos, H. Gensicke et al., “MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial,” Neurology, vol. 75, no. 13, pp. 1141–1149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. A. van Straten, A. Geraedts, I. Verdonck-de Leeuw, G. Andersson, and P. Cuijpers, “Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis,” Journal of Psychosomatic Research, vol. 69, no. 1, pp. 23–32, 2010. View at Publisher · View at Google Scholar · View at Scopus